BioSpace News Archive

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced its financial results for the second quarter ended June 30, 2021 and provided corporate updates.

Amphastar Pharmaceuticals, Inc. today reported results for the three months ended June 30, 2021.

Celcuity today announced financial results for the second quarter ended June 30, 2021 and summarized recent business progress.

Kaleido Biosciences, Inc. today announced the appointment of current Board member Theo Melas-Kyriazi as Chairperson of the Board of Directors effective August 9, 2021.

IGM Biosciences, Inc. today announced its financial results for the second quarter ended June 30, 2021 and provided an update on recent developments.

NuVasive, Inc. today announced the appointment of Amy Belt Raimundo to the Company’s Board of Directors, effective August 9, 2021.

Aethlon Medical, Inc., a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, reported financial results for its first quarter ended June 30, 2021 and provided an update on recent developments.

Catabasis Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.

Athersys, Inc. announced today its financial results for the three months ended June 30, 2021 and provided a corporate update.

Senseonics Holdings, Inc. today reported financial results for the quarter ended June 30, 2021.